StockData
Mesa Laboratories Inc logo

Mesa Laboratories Inc (MLAB) stock

MLABNasdaqIndustrial Instruments For Measurement, Display, and ControlFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3074% above fair value
$139.01+3.81 (+2.82%)

Close on Nov 13, 2026Market cap $777.88MP/E 120.9Yield 0.46%

Earnings

Mesa Laboratories's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 2, 2027
Q3 FY2027 · estimated, before the open
Revenue, Q2 FY2027
$62.34M
+2.6% on a year earlier
Adjusted EPS, Q2 FY2027
$0.75
$2.60 a year earlier
Latest guidance
Issued
Nov 9, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Mesa Laboratories's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q3 FY2027ended Dec 31, 2026Feb 2, 2027Expected–––––
Q2 FY2027ended Sep 30, 2026Nov 9, 2026after the close$62.34M+2.6%$0.75–Release
Q1 FY2027ended Jun 30, 2026Aug 10, 2026after the close$60.14M+1.0%––Release
Q4 FY2026ended Mar 31, 2026May 27, 2026before the open$63.72M+2.6%-$0.75$2.76Release
Q3 FY2026ended Dec 31, 2025Feb 3, 2026before the open$65.13M+3.6%$0.65$3.07Release
Q2 FY2026ended Sep 30, 2025Nov 6, 2025after the close$60.74M+5.0%$0.45$2.60Release
Q1 FY2026ended Jun 30, 2025Aug 5, 2025before the open$59.54M+2.4%$0.85$2.32Release
Q4 FY2025ended Mar 31, 2025May 28, 2025before the open$62.14M+5.5%–$2.23Release
Q3 FY2025ended Dec 31, 2024Feb 4, 2025before the open$62.84M+17.5%-$0.31$2.67Release
Q2 FY2025ended Sep 30, 2024Nov 7, 2024before the open$57.83M+8.8%$0.63$2.62Release
Q1 FY2025ended Jun 30, 2024Aug 5, 2024before the open$58.17M+14.9%$0.62$2.58Release
Q4 FY2024ended Mar 31, 2024Jun 5, 2024before the open$58.90M+6.0%-$47.20$2.29Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Mesa Laboratories's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenuesGAAPFY2027$250.00M – $255.00M–NewNov 9, 2026
adjusted EBITDAnon-GAAPFY2027$66.00M – $68.00M–NewNov 9, 2026

Guidance history

Every forecast Mesa Laboratories put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 9, 2026adjusted EBITDAFY2027$66.00M – $68.00MNew
Nov 9, 2026revenuesFY2027$250.00M – $255.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Mesa Laboratories filed with the SEC as exhibits to Form 8-K or 6-K

  1. Mesa Labs Announces Second Quarter Fiscal Year 2027 Results and Issues First Full-Year Guidance
    Results
  2. Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth
    Update
  3. Mesa Labs Announces First Quarter Results
    Results
  4. Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results
    Results
  5. Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO
    Update
  6. Mesa Labs Announces Third Quarter Results
    Results
  7. Mesa Labs Announces Second Quarter Results
    Results
  8. Mesa Labs Announces First Quarter Results
    Results
  9. Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results
    Results
  10. Mesa Labs Announces Third Quarter Results
    Results
  11. Mesa Labs Announces Second Quarter Results
    Results
  12. Mesa Labs Announces First Quarter Results
    Results
  13. Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
    Results
  14. MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND
    Update
  15. Mesa Labs Announces Third Quarter Results
    Results

See a number that looks wrong?